Dr. Elisa Agostinetto, medical oncologist at the Institute Jules Bordet in...
Trastuzumab deruxtecan (T-DXd) has been approved for the treatment of...
Prof. François Duhoux from Cliniques Universitaires St Luc in Brussels shares...
The NeoRhea study is a phase 2 clinical trial that focuses on patients with...
Genomic signatures have shown promise in predicting the pathological complete...
The standard treatment for hormone receptor-positive HER2-negative advanced...
The benefit of immunotherapy in patients with metastatic breast cancer is...
Dr. Laure-Anne Teuwen, medical oncologist at the university hospital of Antwerp...
Today marks the start of the ASCO 2023 congress, with the first oral abstract...
At the end of the San Antonio breast cancer symposium, Belgian experts were...